Abstract
Intrahepatic cholestasis of pregnancy (ICP) is associated with poor perinatal outcomes in some women such as preterm delivery and fetal demise. Ursodeoxycholic acid (UDCA) is the main therapeutic agent for ICP, but recent evidence failed to show an impact on most perinatal outcomes. Our objective is to summarize the latest evidence in the management of ICP, with a focus on perinatal outcome. We propose a practical approach that combines pharmacotherapy with biochemical and fetal testing, as well as delivery planning.
Similar content being viewed by others
Data Availability
Not applicable (this is a literature review/expert commentary).
Code Availability
Not applicable (this is a literature review/expert commentary).
Each author has confirmed compliance with the journal’s requirements for authorship.
References
Marschall HU, WikströmShemer E, Ludvigsson JF, Stephansson O. Intrahepatic cholestasis of pregnancy and associated hepatobiliary disease: a population-based cohort study. Hepatology. 2013;58(4):1385–91. https://doi.org/10.1002/hep.26444.
Lee RH, Goodwin TM, Greenspoon J, Incerpi M. The prevalence of intrahepatic cholestasis of pregnancy in a primarily Latina Los Angeles population. J Perinatol. 2006;26(9):527–32. https://doi.org/10.1038/sj.jp.7211545.
Abedin P, Weaver JB, Egginton E. Intrahepatic cholestasis of pregnancy: prevalence and ethnic distribution. Ethn Health 4:35–37, 1999. Germain A, Carvajal JA, Glasinovic JC, et al.: Intrahepatic cholestasis of pregnancy. An intriguing pregnancy specific disorder. J Soc Gynecol Invest. 2002;9:10–4.
Reyes H. Intrahepatic cholestasis. A puzzling disorder of pregnancy [review]. J Gastroenterol Hepatol. 1997;12:211–6.
Williamson C, Geenes V. Intrahepatic cholestasis of pregnancy. Obstet Gynecol. 2014;124(1):120–33. https://doi.org/10.1097/AOG.0000000000000346.
Berg B, Helm G, Petersohn I, et al. Cholestasis of pregnancy. Clinical and laboratory studies. Acta Obstet Gynecol Scand. 1986;65:107–13.
van Mil SW, Milona A, Dixon PH, et al. Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy. Gastroenterology. 2007;133:507–16.
Walker IA, Nelson-Piercy C, Williamson C. Role of bile acid measurement in pregnancy. Ann Clin Biochem. 2002;39(Pt 2):105–13. https://doi.org/10.1258/0004563021901856.
Laatikainen T, Ikonen E. Serum bile acids in cholestasis of pregnancy. Obstet Gynecol. 1977;50:313–8.
Laatikainen T, Tulenheimo A. Maternal serum bile acid levels and fetal distress in cholestasis of pregnancy. Int J Gynaecol Obstet. 1984;22:91–4.
Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology. 2004;40:467–74.
Ovadia C, Seed PT, Sklavounos A, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses [published correction appears in Lancet. 2019 Mar 16;393(10176):1100]. Lancet. 2019;393(10174):899–909. https://doi.org/10.1016/S0140-6736(18)31877-4.
Chappell LC, Bell JL, Smith A, et al. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomized controlled trial. The Lancet. 2019;394:849–60.
Ovadia C, Sajous J, Seed PT, et al. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis. Lancet Gastroenterol Hepatol. 2021;S2468–1253(21):00074–81. https://doi.org/10.1016/S2468-1253(21)00074-1.
Beuers U. Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat Clin Pract Gastroenterol Hepatol. 2006;3:318–28.
Palma J, Reyes H, Ribalta J, Hernández I, Sandoval L, Almuna R, Liepins J, Lira F, Sedano M, Silva O. ToháD, Silva JJ: Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo. J Hepatol. 1997;27(6):1022.
Bacq Y, Sentilhes L, Reyes HB, Glantz A, Kondrackiene J, Binder T, Nicastri PL, Locatelli A, Floreani A, Hernandez I, Di Martino V. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis. Gastroenterology. 2012;143(6):1492.
Burrows RF, Clavisi O, Burrows E. Interventions for treating cholestasis in pregnancy. Cochrane Database Syst Rev. 2001;(4):CD000493. https://doi.org/10.1002/14651858.CD000493.
Gurung V, Middleton P, Milan SJ, Hague W, Thornton JG. Interventions for treating cholestasis in pregnancy. Cochrane Database Syst Rev. 2013;6:CD000493.
Obstetric Cholestasis (Green-top Guideline No. 43) https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg43/.
Shen Y, Zhou J, Zhang S, et al. Is it necessary to perform the pharmacological interventions for intrahepatic cholestasis of pregnancy? A Bayesian network meta-analysis. Clin Drug Investig. 2019;39:15–26.
Walker KF, Chappell LC, Hague WM, Middleton P, Thornton JG. Pharmacological interventions for treating intrahepatic cholestasis of pregnancy. Cochrane Database Syst Rev. 2020;7:CD000493. https://doi.org/10.1002/14651858.CD000493.pub3.
Chappell LC, Gurung V, Seed PT, Chambers J, Williamson C, Thornton JG, PITCH Study Consortium. Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial. BMJ. 2012;344:e3799.
Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org, Lee RH, Mara Greenberg, Metz TD, Pettker CM. Society for Maternal-Fetal Medicine Consult Series #53: Intrahepatic cholestasis of pregnancy: Replaces Consult #13, April 2011. Am J Obstet Gynecol. 2021;224(2):B2–B9. https://doi.org/10.1016/j.ajog.2020.11.002.
Fleminger J, Seed PT, Smith A, Juszczak E, Dixon PH, Chambers J, Dorling J, Williamson C, Thornton JG, Chappell LC. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a secondary analysis of the PITCHES trial. BJOG. 2021;128(6):1066–75. https://doi.org/10.1111/1471-0528.16567.
Sentilhes L, Verspyck E, Pia P, Marpeau L. Fetal death in a patient with intrahepatic cholestasis of pregnancy. Obstet Gynecol. 2006;107(2 Pt 2):458–60.
Laatikainen T, Tulenheimo A. Maternal serum bile acid levels and fetal distress in cholestasis of pregnancy. Int J Gynaecol Obstet. 1984;22(2):91–4.
Lee RH, Incerpi MH, Miller DA, Pathak B, Goodwin TM. Sudden fetal death in intrahepatic cholestasis of pregnancy. Obstet Gynecol. 2009;113(2 Pt 2):528–31.
Di Mascio D, Quist-Nelson J, Riegel M, George B, Saccone G, Brun R, Haslinger C, Herrera C, Kawakita T, Lee RH, Benedetti Panici P, Berghella V. Perinatal death by bile acid levels in intrahepatic cholestasis of pregnancy: a systematic review. J Matern Fetal Neonatal Med. 2019;19:1–9.
Geenes V, Chappell LC, Seed PT, Steer PJ, Knight M, Williamson C. Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study. Hepatology. 2014;59(4):1482–91.
Lo JO, Shaffer BL, Allen AJ, Little SE, Cheng YW, Caughey AB. Intrahepatic cholestasis of pregnancy and timing of delivery. J Matern Fetal Neonatal Med. 2015;28(18):2254–8.
Puljic A, Kim E, Page J, Esakoff T, Shaffer B, LaCoursiere DY, Caughey AB. The risk of infant and fetal death by each additional week of expectant management in intrahepatic cholestasis of pregnancy by gestational age. Am J Obstet Gynecol. 2015;212(5):667.e1-5.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics Approval
Not applicable and waived from IRB review (this is a literature review/ expert commentary).
Consent to Participate
Not applicable (this is a literature review/expert commentary).
Consent for Publication
Not applicable (this is a literature review/expert commentary).
Additional information
Précis or Condensation
Ursodeoxycholic acid improves some perinatal outcomes. We propose an updated practical approach to ICP combining pharmacotherapy with biochemical and fetal testing, as well as delivery planning.
Rights and permissions
About this article
Cite this article
Saad, A.F., Pacheco, L.D., Chappell, L. et al. Intrahepatic Cholestasis of Pregnancy: Toward Improving Perinatal Outcome. Reprod. Sci. 29, 3100–3105 (2022). https://doi.org/10.1007/s43032-021-00740-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43032-021-00740-x